Beijing
China
8
2021-12-30
8
2024-11-05
These are the the leading inventors for applications assigned to Eucure (Beijing) Biopharma Co., Ltd.:
Eucure (Beijing) Biopharma Co., Ltd. based in Beijing, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-CD40 antibodies and uses thereof
#2 | 2021-07-08 ✅ Patent 11,292,849 granted on 2022-04-05Anti-TNFRSF9 antibodies and uses thereof
#3 | 2021-07-08 ✅ Patent 11,999,790 granted on 2024-06-04Anti-OX40 antibodies and uses thereof
#4 | 2021-06-24 ✅ Patent 12,054,547 granted on 2024-08-06Anti-CTLA4 antibodies and uses thereof
#5 | 2021-05-27 ✅ Patent 11,142,582 granted on 2021-10-12Anti-CD40 antibodies and uses thereof
#6 | 2020-10-22 ✅ Patent 10,934,365 granted on 2021-03-02Anti-OX40 antibodies and uses thereof
#7 | 2020-10-22 ✅ Patent 11,155,625 granted on 2021-10-26Anti-PD-1 antibodies and uses thereof
#8 | 2020-09-17 ✅ Patent 11,034,764 granted on 2021-06-15Anti-CTLA4 antibodies and uses thereof
Also check out Eucure (Beijing) Biopharma Co., Ltd's (Beijing, China) applicant profile with 13 patent applications submitted.
375744 ⎘